Metraipolis › archive › dc_9369fcd7c381

Radiomics-based outcome prediction for irinotecan-TACE in colorectal liver metastases: advanced analysis from the prospective CIREL trial — Europe PMC PMID:42053592

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42053592
DOI
10.1007/s00330-[numero omesso]-w
License (as archived)
solo-consultazione
Archived
2026-11-02T23:14:46.778Z
SHA-256 of the archived text
26fb64b34c3825776f830b8e57cd2f4fae73ad4f241e901713682f47b09d6631
Stable URL of this page
https://metraipolis.com/documento/dc_9369fcd7c381

How to cite

Radiomics-based outcome prediction for irinotecan-TACE in colorectal liver metastases: advanced analysis from the prospective CIREL trial — Europe PMC PMID:42053592 — Europe PMC (en), https://europepmc.org/article/MED/42053592 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9369fcd7c381 (Metraipolis archive dc_9369fcd7c381, sha256 26fb64b34c3825776f830b8e57cd2f4fae73ad4f241e901713682f47b09d6631)
BibTeX
@misc{dc9369fcd7c381,
  title = {Radiomics-based outcome prediction for irinotecan-TACE in colorectal liver metastases: advanced analysis from the prospective CIREL trial — Europe PMC PMID:42053592},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42053592},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9369fcd7c381; sha256 26fb64b34c3825776f830b8e57cd2f4fae73ad4f241e901713682f47b09d6631},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42053592. Agents can read the archived copy with the MCP tool read_document.